With 1.65 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.49 million shares. The 52-week range on PGEN shows that it touched its highest point at $2.17 and its lowest point at $0.65 during that stretch. It currently has a 1-year price target of $6.00. Beta for the stock currently stands at 1.84.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PGEN was down-trending over the past week, with a drop of -2.92%, but this was down by -14.19% over a month. Three-month performance dropped to -20.36% while six-month performance rose 54.67%. The stock gained 2.31% in the past year, while it has gained 18.75% so far this year. A look at the trailing 12-month EPS for PGEN yields -0.57 with Next year EPS estimates of -0.04. For the next quarter, that number is -0.08. This implies an EPS growth rate of 25.00% for this year and 88.65% for next year.
Float and Shares Shorts:
At present, 295.14 million PGEN shares are outstanding with a float of 161.93 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PGEN since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.43 being high and -$0.47 being low. For PGEN, this leads to a yearly average estimate of -$0.45.
